OR2K2
gene geneOn this page
Also known as HTPCRH06HSHTPCRH06
Summary
OR2K2 (olfactory receptor family 2 subfamily K member 2, HGNC:8264) is a protein-coding gene on chromosome 9q31.3, encoding Olfactory receptor 2K2 (Q8NGT1). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 26248 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 52 total
- MANE Select transcript:
NM_205859
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8264 |
| Approved symbol | OR2K2 |
| Name | olfactory receptor family 2 subfamily K member 2 |
| Location | 9q31.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HTPCRH06, HSHTPCRH06 |
| Ensembl gene | ENSG00000171133 |
| Ensembl biotype | protein_coding |
| Entrez | 26248 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000302681, ENST00000374428
RefSeq mRNA: 1 — MANE Select: NM_205859
NM_205859
CCDS: CCDS6778
Canonical transcript exons
ENST00000302681 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001164573 | 111327229 | 111328482 |
| ENSE00003813603 | 111330106 | 111330224 |
Expression profiles
Bgee: expression breadth broad, 30 present calls, max score 80.30.
Top tissues by expression
97 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.30 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 56.45 | gold quality |
| substantia nigra | UBERON:0002038 | 50.70 | gold quality |
| gastrocnemius | UBERON:0001388 | 50.40 | gold quality |
| muscle of leg | UBERON:0001383 | 49.05 | gold quality |
| tibial nerve | UBERON:0001323 | 44.66 | gold quality |
| Ammon’s horn | UBERON:0001954 | 40.49 | gold quality |
| hypothalamus | UBERON:0001898 | 40.15 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 40.09 | silver quality |
| primary visual cortex | UBERON:0002436 | 39.59 | silver quality |
| bone marrow cell | CL:0002092 | 38.24 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| apex of heart | UBERON:0002098 | 36.91 | gold quality |
| putamen | UBERON:0001874 | 36.80 | silver quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| right atrium auricular region | UBERON:0006631 | 36.37 | gold quality |
| mucosa of stomach | UBERON:0001199 | 36.33 | silver quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 36.22 | gold quality |
| corpus callosum | UBERON:0002336 | 35.90 | gold quality |
| sural nerve | UBERON:0015488 | 35.80 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| bone marrow | UBERON:0002371 | 35.33 | gold quality |
| calcaneal tendon | UBERON:0003701 | 34.57 | gold quality |
| amygdala | UBERON:0001876 | 34.52 | gold quality |
| temporal lobe | UBERON:0001871 | 34.48 | gold quality |
| heart left ventricle | UBERON:0002084 | 34.42 | gold quality |
| heart | UBERON:0000948 | 33.75 | gold quality |
| brain | UBERON:0000955 | 33.12 | gold quality |
| prefrontal cortex | UBERON:0000451 | 33.07 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.31 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Olfactory Receptor OR2K2 Expression in Human Choroid Plexus as a Potential Marker in Early Sporadic Alzheimer’s Disease. (PMID:38540444)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or2k2 | ENSMUSG00000043385 |
| rattus_norvegicus | Or2k2 | ENSRNOG00000089249 |
Paralogs (92): OR2B6 (ENSG00000124657), OR13C9 (ENSG00000136839), OR13C4 (ENSG00000148136), OR2M5 (ENSG00000162727), OR10A5 (ENSG00000166363), OR2D2 (ENSG00000166368), OR2B2 (ENSG00000168131), OR2C1 (ENSG00000168158), OR13J1 (ENSG00000168828), OR10G3 (ENSG00000169208), OR10A3 (ENSG00000170683), OR10A4 (ENSG00000170782), OR10A2 (ENSG00000170790), OR13H1 (ENSG00000171054), OR2M4 (ENSG00000171180), OR10H2 (ENSG00000171942), OR10H5 (ENSG00000172519), OR10AD1 (ENSG00000172640), OR2Y1 (ENSG00000174339), OR10AG1 (ENSG00000174970), OR2T1 (ENSG00000175143), OR10P1 (ENSG00000175398), OR2T35 (ENSG00000177151), OR2M7 (ENSG00000177186), OR2T12 (ENSG00000177201), OR2T33 (ENSG00000177212), OR2AJ1 (ENSG00000177275), OR2T8 (ENSG00000177462), OR2G3 (ENSG00000177476), OR2G2 (ENSG00000177489), OR2B11 (ENSG00000177535), OR2D3 (ENSG00000178358), OR13D1 (ENSG00000179055), OR10A7 (ENSG00000179919), OR2Z1 (ENSG00000181733), OR2V2 (ENSG00000182613), OR10G7 (ENSG00000182634), OR2T29 (ENSG00000182783), OR2T34 (ENSG00000183310), OR2T10 (ENSG00000184022)
Protein
Protein identifiers
Olfactory receptor 2K2 — Q8NGT1 (reviewed: Q8NGT1)
Alternative names: HTPCRH06, Olfactory receptor OR9-17
All UniProt accessions (3): A0A0C4DFP3, A0A494BX18, Q8NGT1
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_995581* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (18 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NGT1-F1 | 86.93 | 0.53 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–188
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 26 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, YGACNNYACAR_UNKNOWN, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_DN, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION
GO Biological Process (4): detection of chemical stimulus involved in sensory perception of smell (GO:0050911), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
224 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR2K2 | FAM222B | Q8WU58 | 463 |
| OR2K2 | PDZD9 | Q8IXQ8 | 454 |
| OR2K2 | CATIP | Q7Z7H3 | 447 |
| OR2K2 | ADGRF3 | Q8IZF5 | 397 |
| OR2K2 | KCNH3 | Q9ULD8 | 370 |
| OR2K2 | TAAR5 | O14804 | 358 |
| OR2K2 | COL20A1 | Q9P218 | 322 |
| OR2K2 | LAMC2 | Q13753 | 307 |
| OR2K2 | RTP1 | P59025 | 296 |
| OR2K2 | PRG4 | Q92954 | 296 |
| OR2K2 | GPR31 | O00270 | 295 |
| OR2K2 | CEP152 | O94986 | 291 |
| OR2K2 | GPRC5D | Q9NZD1 | 290 |
| OR2K2 | GPR37L1 | O60883 | 289 |
| OR2K2 | ECPAS | Q5VYK3 | 280 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR2K2 | NME2P1 | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (9): NME2P1 (Affinity Capture-MS), NME2P1 (Affinity Capture-MS), PAK1 (Affinity Capture-MS), OR2K2 (Affinity Capture-MS), AK1 (Affinity Capture-MS), PAK1 (Affinity Capture-MS), CHMP4A (Affinity Capture-MS), NME2P1 (Affinity Capture-MS), EFHD2 (Affinity Capture-MS)
ESM2 similar proteins: A6NCV1, A6NF89, A6NJZ3, A6NL08, A6NM76, O95221, P0C7N1, P0C7N5, P37070, P37071, P37072, Q15617, Q60886, Q6IEU7, Q8N127, Q8NGE1, Q8NGG0, Q8NGG8, Q8NGP8, Q8NGP9, Q8NGR8, Q8NGS9, Q8NGT0, Q8NGT1, Q8NGX3, Q8NH01, Q8NH10, Q8NH51, Q8NH69, Q8VEW5, Q8VF65, Q8VF66, Q8VF76, Q8VFD0, Q8VFD3, Q8VFK2, Q8VG02, Q8VG03, Q8VG04, Q8VG07
Diamond homologs: A0A2R8YED5, O14581, O43749, O76099, O95221, P0C626, P0C7N1, P0C7N5, P0DN81, P23266, P23275, P30955, P47890, P58173, P58181, P59922, Q15617, Q15619, Q15622, Q60878, Q60881, Q60895, Q6IEU7, Q6UXT6, Q7TQQ0, Q7Z3T1, Q8N0Y5, Q8N146, Q8N162, Q8N628, Q8NG98, Q8NGA1, Q8NGC2, Q8NGE5, Q8NGF4, Q8NGF8, Q8NGG0, Q8NGG3, Q8NGG4, Q8NGG8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
52 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 49 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
213 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:111328337:CAAGG:C | donor_gain | 0.8600 |
| 9:111328332:CA:C | donor_gain | 0.7900 |
| 9:111328363:TCTA:T | donor_gain | 0.6900 |
| 9:111328258:A:C | donor_gain | 0.6200 |
| 9:111327565:C:CC | acceptor_gain | 0.6100 |
| 9:111328336:A:AC | donor_gain | 0.6000 |
| 9:111328337:C:CC | donor_gain | 0.6000 |
| 9:111327759:C:CT | acceptor_gain | 0.5900 |
| 9:111328367:AC:A | donor_gain | 0.5900 |
| 9:111328368:CC:C | donor_gain | 0.5900 |
| 9:111327561:TAAA:T | acceptor_gain | 0.5800 |
| 9:111328333:A:AC | donor_gain | 0.5800 |
| 9:111327560:TTAAA:T | acceptor_gain | 0.5600 |
| 9:111327667:G:C | donor_gain | 0.5500 |
| 9:111328366:A:T | donor_gain | 0.5500 |
| 9:111327696:C:CT | donor_gain | 0.5300 |
| 9:111327758:TC:T | acceptor_gain | 0.5200 |
| 9:111327713:C:CT | donor_gain | 0.5100 |
| 9:111327712:C:CT | donor_gain | 0.5000 |
| 9:111328333:A:C | donor_gain | 0.5000 |
| 9:111328338:A:C | donor_gain | 0.5000 |
| 9:111327687:CAAAA:C | donor_gain | 0.4900 |
| 9:111327691:A:AC | donor_gain | 0.4900 |
| 9:111328366:AAC:A | donor_gain | 0.4900 |
| 9:111327659:G:C | donor_gain | 0.4800 |
| 9:111327796:A:AC | donor_gain | 0.4700 |
| 9:111327797:C:CC | donor_gain | 0.4700 |
| 9:111328017:GC:G | acceptor_gain | 0.4700 |
| 9:111328253:A:C | donor_gain | 0.4700 |
| 9:111327958:TCC:T | acceptor_gain | 0.4600 |
AlphaMissense
2048 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:111327564:A:C | S290R | 0.941 |
| 9:111327564:A:T | S290R | 0.941 |
| 9:111327566:T:G | S290R | 0.941 |
| 9:111328341:G:C | S31R | 0.932 |
| 9:111328341:G:T | S31R | 0.932 |
| 9:111328343:T:G | S31R | 0.932 |
| 9:111328080:C:A | M118I | 0.911 |
| 9:111328080:C:G | M118I | 0.911 |
| 9:111328080:C:T | M118I | 0.911 |
| 9:111327729:C:A | K235N | 0.891 |
| 9:111327729:C:G | K235N | 0.891 |
| 9:111328069:C:G | R122P | 0.890 |
| 9:111328072:T:G | D121A | 0.870 |
| 9:111328071:G:C | D121E | 0.866 |
| 9:111328071:G:T | D121E | 0.866 |
| 9:111328078:G:T | A119E | 0.866 |
| 9:111327579:G:C | N285K | 0.863 |
| 9:111327579:G:T | N285K | 0.863 |
| 9:111327558:T:A | R292S | 0.862 |
| 9:111327558:T:G | R292S | 0.862 |
| 9:111328072:T:A | D121V | 0.862 |
| 9:111328305:G:C | S43R | 0.861 |
| 9:111328305:G:T | S43R | 0.861 |
| 9:111328307:T:G | S43R | 0.861 |
| 9:111327906:G:C | F176L | 0.855 |
| 9:111327906:G:T | F176L | 0.855 |
| 9:111327908:A:G | F176L | 0.855 |
| 9:111327723:A:C | F237L | 0.848 |
| 9:111327723:A:T | F237L | 0.848 |
| 9:111327725:A:G | F237L | 0.848 |
dbSNP variants (sampled 300 via entrez): RS1000271655 (9:111330290 G>A), RS1000721788 (9:111330493 C>T), RS1001016940 (9:111329372 T>A), RS1002734727 (9:111327855 G>A), RS1002860810 (9:111329056 A>G), RS1003108487 (9:111327002 G>C), RS1003456138 (9:111332106 G>A), RS1004610231 (9:111327333 A>G), RS1004887800 (9:111328760 T>G), RS1005089590 (9:111330243 AAATT>A), RS1006662409 (9:111327237 G>C), RS1007161765 (9:111329946 C>A,T), RS1007748955 (9:111328573 A>G,T), RS1008240554 (9:111328796 T>C), RS1008369520 (9:111331320 A>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001137_7 | White blood cell count | 2.000000e-22 |
| GCST002541_77 | Menarche (age at onset) | 1.000000e-08 |
| GCST002541_78 | Menarche (age at onset) | 2.000000e-23 |
| GCST007927_16 | Medication use (beta blocking agents) | 7.000000e-09 |
| GCST011946_18 | White matter hyperintensity volume | 4.000000e-06 |
| GCST011947_23 | White matter hyperintensity volume | 2.000000e-06 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005091 | monocyte count |
| EFO:0004703 | age at menarche |
| EFO:0009929 | Beta blocking agent use measurement |
| EFO:0005665 | white matter hyperintensity measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | increases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
| Lactic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.